Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-70,990
Closed -$12M 140
2024
Q1
$12M Sell
70,990
-33,400
-32% -$6.26M 0.57% 68
2023
Q4
$20.6M Buy
104,390
+800
+0.8% +$142K 1.43% 21
2023
Q3
$18M Sell
103,590
-2,500
-2% -$454K 1.23% 24
2023
Q2
$18.3M Buy
106,090
+34,200
+48% +$5.91M 1.29% 28
2023
Q1
$12M Buy
+71,890
New +$11.8M 0.71% 65

Other funds holding ZTS

Payden & Rygel's ZTS Position: Q2 2024 in Review

Payden & Rygel sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 70,990 shares — an estimated $12M sold.

Payden & Rygel first reported a position in ZTS in Q1 2023 and held it in 5 quarters. The position peaked at $20.6M in Q4 2023. 1,738 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

  • Payden & Rygel reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
  • Payden & Rygel sold 70,990 Zoetis shares in Q2 2024, an estimated $12M.
  • Payden & Rygel first reported a position in Zoetis in Q1 2023 and held it in 5 quarters.
  • Payden & Rygel's Zoetis position peaked at $20.6M in Q4 2023.
  • 1,738 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on Payden & Rygel's 13F filing for Q2 2024, filed 7 Oct 2024.